Global GERD & NERD Treatment Market Size By Type (Antacids (Acid Neutralizers), Proton Pump Inhibitors), By Application (Hospitals & Clinics, Research Centers), By Region, And Segment Forecasts, 2023...

Report Id: 22716 | Published Date: Jun 2026 | No. of Pages: | Base Year for Estimate: Jun 2026 | Format:


The Global GERD (Gastroesophageal Reflux Disease) & NERD (Non-Erosive Reflux Disease) Treatment Market was valued at USD XX billion in 2023 and is projected to surpass USD XX billion by 2031, growing at a CAGR of XX% during the forecast period of 2023-2031. The increasing prevalence of gastroesophageal reflux disorders due to changing dietary habits, obesity, and lifestyle stress is fueling market growth. Advancements in drug formulations, increasing adoption of minimally invasive surgeries, and growing awareness of acid reflux treatment options are key contributors to market expansion.

Market Drivers:

Rising Prevalence of GERD & NERD:

A significant portion of the global population suffers from GERD and NERD due to sedentary lifestyles, unhealthy eating habits, and obesity. The growing disease burden is driving the demand for effective treatment solutions.

Increasing Adoption of Proton Pump Inhibitors (PPIs) & H2 Receptor Antagonists:

PPIs and H2 receptor blockers are the first-line treatment for GERD & NERD. Their efficacy in reducing gastric acid production has led to their widespread use globally.

Advancements in Drug Development & Minimally Invasive Therapies:

The introduction of innovative drugs, including potassium-competitive acid blockers (P-CABs) and novel formulations of antacids, is shaping market growth. Additionally, minimally invasive procedures such as LINX Reflux Management System and transoral incisionless fundoplication (TIF) are gaining traction.

Market Restraints:

Side Effects & Long-Term Risks of GERD Medications:

Chronic use of PPIs has been associated with adverse effects, including kidney disease, fractures, and gut microbiome imbalance, limiting long-term adoption.

High Cost of Advanced Surgical Treatments:

While surgeries like fundoplication provide effective relief, their high costs and limited insurance coverage in some regions restrict patient access.

Market Opportunities:

Emerging Markets & Increasing Healthcare Access:

Developing economies in Asia-Pacific and Latin America present significant growth opportunities due to rising healthcare infrastructure investments and increasing patient awareness.

Development of Novel Therapeutics & Drug Delivery Systems:

Pharmaceutical companies are focusing on advanced drug formulations, such as extended-release PPIs and combination therapies, to improve treatment efficacy and patient compliance.

Rising Popularity of Alternative & Herbal Treatments:

Increasing preference for natural and herbal remedies for acid reflux, such as aloe vera, ginger, and probiotics, is creating a niche segment in the market.

Market by Treatment Type Insights:

Pharmacological Treatment:

Proton Pump Inhibitors (PPIs)

H2 Receptor Antagonists

Antacids

Potassium-Competitive Acid Blockers (P-CABs)

Surgical & Device-Based Treatment:

Fundoplication

LINX Reflux Management System

Transoral Incisionless Fundoplication (TIF)

Market by End-Use Insights:

Hospitals & Clinics:

The primary treatment centers for GERD & NERD, offering medication prescriptions and surgical interventions.

Retail & Online Pharmacies:

The fastest-growing distribution channel for over-the-counter antacids, PPIs, and dietary supplements.

Market by Regional Insights:

North America dominates the market due to a high prevalence of GERD, well-established healthcare infrastructure, and widespread use of PPIs.

Europe follows closely, driven by rising obesity rates and an aging population prone to acid reflux disorders.

Asia-Pacific is the fastest-growing region, with an increasing number of patients, growing disposable incomes, and expanding healthcare access.

Latin America & Middle East & Africa are emerging markets witnessing gradual growth due to improving healthcare facilities and increasing disease awareness.

Competitive Scenario:

Leading players in the Global GERD & NERD Treatment Market include:

AstraZeneca

Takeda Pharmaceuticals

Johnson & Johnson

GlaxoSmithKline (GSK)

Pfizer Inc.

Eisai Co., Ltd.

Boehringer Ingelheim

Medtronic plc (for surgical treatment devices)

These companies are focusing on R&D investments, new drug approvals, and strategic mergers to strengthen their market presence.

Scope of Work – Global GERD & NERD Treatment Market

Report Metric

Details

Market Size (2023)

USD XX billion

Projected Market Size (2031)

USD XX billion

CAGR (2023-2031)

XX%

Key Segments by Treatment Type

Pharmacological (PPIs, H2 Antagonists, Antacids, P-CABs), Surgical (Fundoplication, LINX System)

Key Segments by End-Use

Hospitals, Clinics, Retail Pharmacies, Online Pharmacies

Leading Region

North America

Key Players

AstraZeneca, Takeda, GSK, Pfizer, Johnson & Johnson, Medtronic

Growth Drivers

Rising disease prevalence, increased drug adoption, new surgical techniques

Opportunities

Expansion in emerging markets, novel drug development, alternative medicine trends

Key Market Developments:

2023: AstraZeneca launched an improved formulation of Esomeprazole for enhanced acid suppression.

2023: Medtronic received FDA approval for its next-generation LINX Reflux Management System.

2024: Takeda Pharmaceuticals announced the development of a novel potassium-competitive acid blocker (P-CAB) with reduced side effects.

2025: Pfizer entered a strategic partnership to distribute its latest GERD medication in emerging markets.

FAQs:

1. What is the current market size of the Global GERD & NERD Treatment Market?

The market was valued at USD XX billion in 2023 and is expected to grow significantly by 2031.

2. What is the major growth driver of the Global GERD & NERD Treatment Market?

The rising prevalence of GERD & NERD, increasing adoption of PPIs, and advancements in minimally invasive surgical treatments are key growth drivers.

3. Which is the largest region during the forecast period in the Global GERD & NERD Treatment Market?

North America is the leading market due to the high incidence of GERD, increasing healthcare expenditure, and strong pharmaceutical presence.

4. Which segment accounted for the largest market share in the Global GERD & NERD Treatment Market?

The pharmacological treatment segment dominated in 2023, particularly proton pump inhibitors (PPIs), due to their widespread use and effectiveness.

5. Who are the key market players in the Global GERD & NERD Treatment Market?

Leading players include AstraZeneca, Takeda Pharmaceuticals, Pfizer, GSK, Medtronic, and Johnson & Johnson, among others.

This comprehensive report provides an SEO-friendly and data-driven analysis of the Global GERD & NERD Treatment Market, covering key trends, drivers, restraints, opportunities, competitive landscape, and future projections. 🚀 

Download Sample Report

Speak with an analyst to get exclusive insights tailored to your needs

Related Reports

Related report image
Global Venous thromboembolism(VTE)Therapeutics Market By Type (Deep Vein Thrombosis(DVT),Pulmonary E...

The Global Venous Thromboembolism (VTE) Therapeutics Market was valued at USD 1.8 billion in 2023 an...

Read More
Related report image
Global Vein Illumination Device Market By Type (Transillumination, Infrared Technology, Ultrasound)...

The Global Vein Illumination Device Market was valued at USD 200 million in 2023 and is projected to...

Read More
Related report image
Global Vasculitis Treatment Market By Type (Large Vasculitis Treatment, Medium Vasculitis Treatment,...

The Global Vasculitis Treatment Market was valued at USD 500 million in 2023 and is projected to rea...

Read More
Related report image
Global Vascular Guidewires Market By Type (Nitinol, Stainless Steel, Hybrid), By Application (Hospi...

The Global Vascular Guidewires Market was valued at USD 1.3 billion in 2023 and is projected to reac...

Read More
Related report image
Global Vagus nerve stimulation Market By Type (Implantable VNS Devices, External VNS Devices), By Ap...

The Global Vagus Nerve Stimulation (VNS) Market was valued at USD 625 million in 2023 and is projec...

Read More
Related report image
Global In-line UV-Vis Spectroscopy Market By Type (Color Measurement, Chemical Concentration, Turbid...

The In-line UV-Vis Spectroscopy Market is expected to grow at a CAGR of 10.2% between 2023 and 2030,...

Read More
Related report image
Global Venturi Masks Market By Type (24% Oxygen Masks, 28% Oxygen Masks, 31% Oxygen Masks, 35% Oxyge...

Between the years 2023 and 2030, it is anticipated that the Global Venturi Masks Market will experie...

Read More
Related report image
Global Knee Massager Market By Type (Knee Massager,Knuckle Massager,Elbow Massager), By Application...

The growing awareness of joint health and the rising incidence of knee-related conditions like arthr...

Read More
Related report image
Global Mechanical Thrombectomy Devices Market By Type (Stroke, Deep Vein Thrombosis (DVT), Pulmonary...

The Global Mechanical Thrombectomy Devices Market was valued at USD 1.3 billion in 2023 and is proje...

Read More
Related report image
Global Vaginal Slings Market By Type (Biologic, Synthetic Slings), By Application (Clinics, Hospital...

The Global Vaginal Slings Market was valued at USD 1.1 billion in 2023 and is projected to reach USD...

Read More